Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563].
Saved in:
| Title: | Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]. |
|---|---|
| Authors: | Zhao F; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China., Yang H; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Gao Z; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China., Liu H; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Wu P; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Li B; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Yu H; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China., Shao J; Department of Neurology, Wenling First People's Hospital Affiliated to Wenzhou Medical University, Wenling 317500, China. |
| Source: | Heliyon [Heliyon] 2025 Nov 12; Vol. 11 (16), pp. e44134. Date of Electronic Publication: 2025 Nov 12 (Print Publication: 2025). |
| Publication Type: | Journal Article; Retraction Notice |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41395411 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhao+F%22">Zhao F</searchLink>; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China.<br /><searchLink fieldCode="AU" term="%22Yang+H%22">Yang H</searchLink>; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China.<br /><searchLink fieldCode="AU" term="%22Gao+Z%22">Gao Z</searchLink>; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China.<br /><searchLink fieldCode="AU" term="%22Wu+P%22">Wu P</searchLink>; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China.<br /><searchLink fieldCode="AU" term="%22Li+B%22">Li B</searchLink>; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China.<br /><searchLink fieldCode="AU" term="%22Shao+J%22">Shao J</searchLink>; Department of Neurology, Wenling First People's Hospital Affiliated to Wenzhou Medical University, Wenling 317500, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101672560%22">Heliyon</searchLink> [Heliyon] 2025 Nov 12; Vol. 11 (16), pp. e44134. <i>Date of Electronic Publication: </i>2025 Nov 12 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Retraction Notice – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101672560 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2405-8440 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224058440%22">24058440 </searchLink><i>NLM ISO Abbreviation: </i>Heliyon <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41395411 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.heliyon.2025.e44134 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e44134 Titles: – TitleFull: Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhao F – PersonEntity: Name: NameFull: Yang H – PersonEntity: Name: NameFull: Gao Z – PersonEntity: Name: NameFull: Liu H – PersonEntity: Name: NameFull: Wu P – PersonEntity: Name: NameFull: Li B – PersonEntity: Name: NameFull: Yu H – PersonEntity: Name: NameFull: Shao J IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 11 Text: 2025 Nov 12 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2405-8440 Numbering: – Type: volume Value: 11 – Type: issue Value: 16 Titles: – TitleFull: Heliyon Type: main |
| ResultId | 1 |
